colorectal cancer

Chi-Med’s fruquintinib gets approval for colorectal cancer in China

Hutchison China MediTech (Chi-Med) has secured approval from the National Medical Products Administration of China (NMPA) for the use of…

Array BioPharma’s mCRC therapy gets breakthrough status

Array BioPharma has received breakthrough therapy designation from the US Food and Drug Administration (FDA) to use encorafenib (Braftovi) in…